PEAK BIO INC's ticker is and the CUSIP is 70470P108. A total of 10 filers reported holding PEAK BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $60,261 | – | 14,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 497,528 | $2,021,792 | 0.17% |
| Tower Research Capital LLC (TRC) | 3,161 | $14 | 0.00% |
| WELLS FARGO & COMPANY/MN | 49 | $205 | 0.00% |
| NORTHERN TRUST CORP | 14,382 | $60,261 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 51,092 | $214 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 38,631 | $161,864 | 0.00% |
| GOLDMAN SACHS GROUP INC | 13,716 | $57,470 | 0.00% |
| MORGAN STANLEY | 278 | $1,165 | 0.00% |
| UBS Group AG | 719 | $3,013 | 0.00% |